Inceptionr LLC purchased a new stake in Teleflex Incorporated (NYSE:TFX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 5,181 shares of the medical technology company’s stock, valued at approximately $922,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Teleflex by 72.7% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 3,177 shares of the medical technology company’s stock valued at $786,000 after acquiring an additional 1,337 shares in the last quarter. Janney Montgomery Scott LLC boosted its holdings in shares of Teleflex by 0.4% during the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after acquiring an additional 65 shares in the last quarter. Robeco Institutional Asset Management B.V. acquired a new stake in shares of Teleflex during the 3rd quarter valued at $687,000. QRG Capital Management Inc. acquired a new stake in shares of Teleflex during the 3rd quarter valued at $509,000. Finally, Principal Financial Group Inc. boosted its holdings in shares of Teleflex by 2.7% during the 3rd quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company’s stock valued at $19,887,000 after acquiring an additional 2,086 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on TFX shares. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Piper Sandler reissued a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Royal Bank of Canada downgraded Teleflex from an “outperform” rating to a “sector perform” rating and cut their target price for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Wells Fargo & Company cut their target price on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. Finally, Truist Financial cut their target price on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a report on Monday. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Teleflex presently has an average rating of “Hold” and a consensus target price of $182.63.
Teleflex Stock Up 1.6 %
Shares of NYSE:TFX opened at $136.32 on Friday. The company has a market capitalization of $6.32 billion, a price-to-earnings ratio of 27.10, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The business’s 50-day moving average is $171.92 and its 200-day moving average is $202.22. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.90.
Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Equities research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.
Teleflex Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex’s dividend payout ratio is 95.77%.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
- Five stocks we like better than Teleflex
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Where Do I Find 52-Week Highs and Lows?
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.